MGTX Competitors & Alternatives
Compare MeiraGTx Holdings PLC with similar stocks in the same industry
Biotechnology
MGTX
Main Stock$12.73
Tradestie Score
59
Market Cap
$665.30M
Revenue Growth
-0.8%
Analyst Upside
+122.9%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$8.26
|
$1.29B | 119.1 | 61 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$29.47
|
$1.29B | - | 50 | Compare |
|
ARDX
Ardelyx, Inc.
|
$5.19
|
$1.29B | - | 52 | Compare |
|
ZYME
Zymeworks Inc.
|
$24.98
|
$1.28B | - | 54 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$6.06
|
$1.27B | - | 55 | Compare |
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$44.80
|
$1.26B | - | 61 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 58 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$5.74
|
$1.22B | - | 63 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$5.13
|
$1.18B | - | 59 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$51.82
|
$1.17B | - | 63 | Compare |
More MGTX Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry